Detalhe da pesquisa
1.
Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
J Biol Chem
; 288(41): 29901-10, 2013 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23990460
2.
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
Blood
; 113(14): 3314-22, 2009 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188669
3.
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.
Blood Cancer Discov
; 1(2): 162-177, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32954361
4.
Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.
Leuk Res
; 42: 68-74, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26818573
5.
Decreased T-cell proliferation and skewed immune responses in LLC-bearing mice.
J Environ Pathol Toxicol Oncol
; 24(3): 175-92, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16050802
6.
Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.
Cell Rep
; 11(5): 808-20, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25921540
7.
Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
Hum Immunol
; 64(12): 1160-6, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14630398
8.
Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.
Leuk Res
; 38(11): 1309-15, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25282333
9.
Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms.
Mol Neurobiol
; 41(2-3): 420-5, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20422315
10.
Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.
Cancer Res
; 70(24): 10234-42, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21159644
11.
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.
Cancer Immunol Immunother
; 53(5): 422-30, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14648070